Dear Doctor Letter (Rote-Hand-Brief) on Pedea® (ibuprofen as solution for injection): Shortage
2013.07.22
Active substance: ibuprofen
A temporary shortage in the supply of the medicinal product Pedea® for treatment of a haemodynamically significant patent ductus arteriosus Botalli in preterm newborn infants less than 34 weeks of gestational age has arisen due to the development of visible particles in the ampoules.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN